These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

412 related articles for article (PubMed ID: 30286791)

  • 1. Deep proteomic network analysis of Alzheimer's disease brain reveals alterations in RNA binding proteins and RNA splicing associated with disease.
    Johnson ECB; Dammer EB; Duong DM; Yin L; Thambisetty M; Troncoso JC; Lah JJ; Levey AI; Seyfried NT
    Mol Neurodegener; 2018 Oct; 13(1):52. PubMed ID: 30286791
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteomic landscape of Alzheimer's Disease: novel insights into pathogenesis and biomarker discovery.
    Bai B; Vanderwall D; Li Y; Wang X; Poudel S; Wang H; Dey KK; Chen PC; Yang K; Peng J
    Mol Neurodegener; 2021 Aug; 16(1):55. PubMed ID: 34384464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dissecting Detergent-Insoluble Proteome in Alzheimer's Disease by TMTc-Corrected Quantitative Mass Spectrometry.
    Zaman M; Fu Y; Chen PC; Sun H; Yang S; Wu Z; Wang Z; Poudel S; Serrano GE; Beach TG; Li L; Wang X; Peng J
    Mol Cell Proteomics; 2023 Aug; 22(8):100608. PubMed ID: 37356496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Global quantitative analysis of the human brain proteome and phosphoproteome in Alzheimer's disease.
    Ping L; Kundinger SR; Duong DM; Yin L; Gearing M; Lah JJ; Levey AI; Seyfried NT
    Sci Data; 2020 Sep; 7(1):315. PubMed ID: 32985496
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Network Analysis of a Membrane-Enriched Brain Proteome across Stages of Alzheimer's Disease.
    Higginbotham L; Dammer EB; Duong DM; Modeste E; Montine TJ; Lah JJ; Levey AI; Seyfried NT
    Proteomes; 2019 Aug; 7(3):. PubMed ID: 31461916
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative proteomics of cerebrospinal fluid from African Americans and Caucasians reveals shared and divergent changes in Alzheimer's disease.
    Modeste ES; Ping L; Watson CM; Duong DM; Dammer EB; Johnson ECB; Roberts BR; Lah JJ; Levey AI; Seyfried NT
    Mol Neurodegener; 2023 Jul; 18(1):48. PubMed ID: 37468915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrated proteomics and network analysis identifies protein hubs and network alterations in Alzheimer's disease.
    Zhang Q; Ma C; Gearing M; Wang PG; Chin LS; Li L
    Acta Neuropathol Commun; 2018 Mar; 6(1):19. PubMed ID: 29490708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrated Proteomics to Understand the Role of Neuritin (NRN1) as a Mediator of Cognitive Resilience to Alzheimer's Disease.
    Hurst C; Pugh DA; Abreha MH; Duong DM; Dammer EB; Bennett DA; Herskowitz JH; Seyfried NT
    Mol Cell Proteomics; 2023 May; 22(5):100542. PubMed ID: 37024090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proteomic Profiling of Plasma and Brain Tissue from Alzheimer's Disease Patients Reveals Candidate Network of Plasma Biomarkers.
    Chen M; Xia W
    J Alzheimers Dis; 2020; 76(1):349-368. PubMed ID: 32474469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrated analysis of ultra-deep proteomes in cortex, cerebrospinal fluid and serum reveals a mitochondrial signature in Alzheimer's disease.
    Wang H; Dey KK; Chen PC; Li Y; Niu M; Cho JH; Wang X; Bai B; Jiao Y; Chepyala SR; Haroutunian V; Zhang B; Beach TG; Peng J
    Mol Neurodegener; 2020 Jul; 15(1):43. PubMed ID: 32711556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in the detergent-insoluble brain proteome linked to amyloid and tau in Alzheimer's Disease progression.
    Hales CM; Dammer EB; Deng Q; Duong DM; Gearing M; Troncoso JC; Thambisetty M; Lah JJ; Shulman JM; Levey AI; Seyfried NT
    Proteomics; 2016 Dec; 16(23):3042-3053. PubMed ID: 27718298
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Multi-network Approach Identifies Protein-Specific Co-expression in Asymptomatic and Symptomatic Alzheimer's Disease.
    Seyfried NT; Dammer EB; Swarup V; Nandakumar D; Duong DM; Yin L; Deng Q; Nguyen T; Hales CM; Wingo T; Glass J; Gearing M; Thambisetty M; Troncoso JC; Geschwind DH; Lah JJ; Levey AI
    Cell Syst; 2017 Jan; 4(1):60-72.e4. PubMed ID: 27989508
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Flow-cytometric microglial sorting coupled with quantitative proteomics identifies moesin as a highly-abundant microglial protein with relevance to Alzheimer's disease.
    Rayaprolu S; Gao T; Xiao H; Ramesha S; Weinstock LD; Shah J; Duong DM; Dammer EB; Webster JA; Lah JJ; Wood LB; Betarbet R; Levey AI; Seyfried NT; Rangaraju S
    Mol Neurodegener; 2020 May; 15(1):28. PubMed ID: 32381088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Global Profiling of Lysine Accessibility to Evaluate Protein Structure Changes in Alzheimer's Disease.
    Yu K; Niu M; Wang H; Li Y; Wu Z; Zhang B; Haroutunian V; Peng J
    J Am Soc Mass Spectrom; 2021 Apr; 32(4):936-945. PubMed ID: 33683887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Large-scale deep multi-layer analysis of Alzheimer's disease brain reveals strong proteomic disease-related changes not observed at the RNA level.
    Johnson ECB; Carter EK; Dammer EB; Duong DM; Gerasimov ES; Liu Y; Liu J; Betarbet R; Ping L; Yin L; Serrano GE; Beach TG; Peng J; De Jager PL; Haroutunian V; Zhang B; Gaiteri C; Bennett DA; Gearing M; Wingo TS; Wingo AP; Lah JJ; Levey AI; Seyfried NT
    Nat Neurosci; 2022 Feb; 25(2):213-225. PubMed ID: 35115731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A proteomics analysis of 5xFAD mouse brain regions reveals the lysosome-associated protein Arl8b as a candidate biomarker for Alzheimer's disease.
    Boeddrich A; Haenig C; Neuendorf N; Blanc E; Ivanov A; Kirchner M; Schleumann P; Bayraktaroğlu I; Richter M; Molenda CM; Sporbert A; Zenkner M; Schnoegl S; Suenkel C; Schneider LS; Rybak-Wolf A; Kochnowsky B; Byrne LM; Wild EJ; Nielsen JE; Dittmar G; Peters O; Beule D; Wanker EE
    Genome Med; 2023 Jul; 15(1):50. PubMed ID: 37468900
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A proteomic network approach resolves stage-specific molecular phenotypes in chronic traumatic encephalopathy.
    Gutierrez-Quiceno L; Dammer EB; Johnson AG; Webster JA; Shah R; Duong D; Yin L; Seyfried NT; Alvarez VE; Stein TD; McKee AC; Hales CM
    Mol Neurodegener; 2021 Jun; 16(1):40. PubMed ID: 34172091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted Quantification of Detergent-Insoluble RNA-Binding Proteins in Human Brain Reveals Stage and Disease Specific Co-aggregation in Alzheimer's Disease.
    Guo Q; Dammer EB; Zhou M; Kundinger SR; Gearing M; Lah JJ; Levey AI; Shulman JM; Seyfried NT
    Front Mol Neurosci; 2021; 14():623659. PubMed ID: 33815056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. APOER2 splicing repertoire in Alzheimer's disease: Insights from long-read RNA sequencing.
    Gallo CM; Kistler SA; Natrakul A; Labadorf AT; Beffert U; Ho A
    PLoS Genet; 2024 Jul; 20(7):e1011348. PubMed ID: 39038048
    [TBL] [Abstract][Full Text] [Related]  

  • 20. U1 small nuclear ribonucleoprotein complex and RNA splicing alterations in Alzheimer's disease.
    Bai B; Hales CM; Chen PC; Gozal Y; Dammer EB; Fritz JJ; Wang X; Xia Q; Duong DM; Street C; Cantero G; Cheng D; Jones DR; Wu Z; Li Y; Diner I; Heilman CJ; Rees HD; Wu H; Lin L; Szulwach KE; Gearing M; Mufson EJ; Bennett DA; Montine TJ; Seyfried NT; Wingo TS; Sun YE; Jin P; Hanfelt J; Willcock DM; Levey A; Lah JJ; Peng J
    Proc Natl Acad Sci U S A; 2013 Oct; 110(41):16562-7. PubMed ID: 24023061
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.